within Pharmacolibrary.Drugs.A_AlimentaryTractAndMetabolism.A03B_BelladonnaAndDerivativesPlain.A03BA03_Hyoscyamine;

model Hyoscyamine
  extends Pharmacolibrary.Pharmacokinetic.Models.PK_1C_enteral(
    weight = 70,
    F = 0.86,
    Cl = 1.827777777777778e-05,
    adminDuration = 600,
    adminMass = 0.375 / 1000000,
    adminCount = 1,
    Vd = 0.0063,
    Cmin = 0.001,
    Cmax = 0.01,
    Ctox_peak = 0.02,
    Ctox_trough = 0.01,
    ka = 0.012333333333333333,
    Tlag = 600);

  annotation (Documentation(
    info       = "<html><body><table><tr><td>name:</td><td>Hyoscyamine</td></tr><tr><td>ATC code:</td><td>A03BA03</td></tr><td>route:</td><td>oral</td></tr>
    <tr><td>compartments:</td><td>1</td></tr>
    <tr><td>dosage:</td><td>0.375</td><td>mg</td></tr>
    <tr><td>volume of distribution:</td><td>6.3</td><td>L</td></tr>
    <tr><td>clearance:</td><td>0.94</td><td>L/hr/kg</td></tr>
    <tr><td colspan='3'>other parameters in model implementation</td></tr>
    </table><p>Hyoscyamine is an anticholinergic (antimuscarinic) alkaloid derived from plants such as Atropa belladonna and Datura stramonium. It is used medically to treat a variety of gastrointestinal disorders (like peptic ulcer and irritable bowel syndrome), to reduce secretions, and as an adjunct in anesthesia. Hyoscyamine is approved and marketed today, often as part of combination products.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetics in healthy adults following single oral administration.</p><h4>References</h4><ol></ol></body></html>",
    revisions  = "<html><body><ul><li>10/2026 Pharmacolibrary 26.09: model of Drugs.ATC.A.A03BA03 folded in (Drugs.ATC removed)</li><li>06/2025 Tomas Kulhanek, generated model from data extracted from PUBMED, DrugBank and LLM(GPT4.1)</li></ul></body></html>",
    experiment (StartTime = 0, StopTime = 86400, Tolerance = 1e-9, Interval = 1)
  ));
    
end Hyoscyamine;
